AstraZeneca (AZN)

• Market cap: $237B
• 1 day: 1.24%
• 5 days: -1.52%
• 1 month: 2.77%
• 3 months: 14.91%
• 6 months: -2.25%
• Year to date: 16.14%
• 1 year: 13.21%
• 5 years: 80.96%
• 10 years: 127.17%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Employees: 94,300

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

39% more call options, than puts

Call options by funds: $491M | Put options by funds: $354M

1.66% more ownership

Funds ownership: 31.46% [Q3] → 33.12% (+1.66%) [Q4]

5% more first-time investments, than exits

New positions opened: 155 | Existing positions closed: 148

1% less repeat investments, than reductions

Existing positions increased: 419 | Existing positions reduced: 422

2% less funds holding

Funds holding: 1,212 [Q3] → 1,192 (-20) [Q4]

10% less capital invested

Capital invested by funds: $38B [Q3] → $34.1B (-$3.93B) [Q4]

19% less funds holding in top 10

Funds holding in top 10: 16 [Q3] → 13 (-3) [Q4]